216 related articles for article (PubMed ID: 10759619)
1. Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers.
Kees F; Holstege A; Ittner KP; Zimmermann M; Lock G; Schölmerich J; Grobecker H
Aliment Pharmacol Ther; 2000 Apr; 14(4):407-12. PubMed ID: 10759619
[TBL] [Abstract][Full Text] [Related]
2. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
4. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
Malaty H; el-Zimaity HM; Genta RM; Cole RA; Graham DY
Aliment Pharmacol Ther; 1996 Dec; 10(6):1001-4. PubMed ID: 8971301
[TBL] [Abstract][Full Text] [Related]
5. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
6. Lack of pharmacokinetic interaction after administration of lansoprazole or omeprazole with prednisone.
Cavanaugh JH; Karol MD
J Clin Pharmacol; 1996 Nov; 36(11):1064-71. PubMed ID: 8973995
[TBL] [Abstract][Full Text] [Related]
7. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N
Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
[TBL] [Abstract][Full Text] [Related]
8. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole--an open pilot study.
Pohle T; Stoll R; Kirchner T; Heep M; Lehn N; Bock H; Domschke W
Aliment Pharmacol Ther; 1998 Dec; 12(12):1273-8. PubMed ID: 9882038
[TBL] [Abstract][Full Text] [Related]
10. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between acetaminophen and lansoprazole.
Sanaka M; Kuyama Y; Mineshita S; Qi J; Hanada Y; Enatsu I; Tanaka H; Makino H; Yamanaka M
J Clin Gastroenterol; 1999 Jul; 29(1):56-8. PubMed ID: 10405233
[TBL] [Abstract][Full Text] [Related]
13. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
14. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg.
Katz PO; Xue S; Castell DO
Aliment Pharmacol Ther; 2001 May; 15(5):647-52. PubMed ID: 11328258
[TBL] [Abstract][Full Text] [Related]
15. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
Midolo PD; Turnidge JD; Lambert JR; Bell JM
Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
[TBL] [Abstract][Full Text] [Related]
16. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
Midolo PD; Turnidge JD; Lambert JR
J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Fuchs W; Richter G; Burkhardt F; Wolf N; Walter TA
Aliment Pharmacol Ther; 1997 Apr; 11(2):359-64. PubMed ID: 9146776
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
[TBL] [Abstract][Full Text] [Related]
20. Effect of lansoprazole on Helicobacter pylori.
Lamouliatte H
Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
